4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-020572
Director sold 9,900 shares at $3.39 ($33,528)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stuglik Brian M Director | 2024-06-13 | Sale 10b5-1 | −9,900 | $3.39 | $33,528 | 49,058 | D |
| Open-market sales · 9,900 sh · avg $3.39 · $33,528 | |||||||
Loading xslF345X05/rdgdoc.xml…